Takeda Pharmaceutical Company Limited (TAK)

Trade TAK now with
7/20/2022 8:48:36 AM F-star Therapeutics Enters License Deal With Takeda To Develop Bispecific Antibody
6/27/2022 6:03:05 AM Takeda Publishes Results From Phase 2 Study Of Fazirsiran In New England Journal Of Medicine
6/22/2022 6:59:06 AM Takeda Inks 15-year Lease With BioMed Realty For R&D And Office Space To Be Built In Kendall Square
6/9/2022 4:34:17 AM Takeda Says Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Thro 4.5 Yrs In Clinical Trial
6/7/2022 11:03:10 AM Takeda Canada Welcomes Quebec's New Rare Disease Policy
5/31/2022 4:20:53 AM Takeda, Moderna Announce Plans To Transfer Marketing Authorization For Spikevax COVID-19 Vaccine In Japan To Moderna
5/11/2022 2:21:15 AM Takeda Reports FY Revenue Growth Of 11.6%
4/18/2022 8:04:21 AM Takeda Announces Availability Of TAKHZYRO Injection Single-dose Prefilled Syringe In The U.S.
4/13/2022 2:17:34 AM Takeda Announces Completion Of Acquisition Of Own Shares
4/12/2022 7:04:35 AM Takeda Says Phase 3 SHP643-301 Study Evaluating Safety Profile And Pharmacokinetics Of TAKHZYRO Meets Objectives
2/28/2022 7:06:35 AM Takeda : Interim Phase 4 Data Support TAKHZYRO As Effective Treatment To Reduce Attacks In Hereditary Angioedema
2/18/2022 6:55:26 AM Takeda : Alofisel Shows Clinical Remission Rate At Six-Months In INSPIRE Study Interim Analysis On Crohn's Disease